BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7376700)

  • 1. [Oxyfedrine in the therapy of coronary disease].
    Wallner H; Sternitzke N; Schieffer H
    ZFA (Stuttgart); 1980 Mar; 56(9):612-6. PubMed ID: 7376700
    [No Abstract]   [Full Text] [Related]  

  • 2. [Positive inotropic effect of coronary-active drug: oxyfedrine].
    Conti G; Moreschini G; Pelosi M
    Minerva Cardioangiol; 1980 Sep; 28(9):645-7. PubMed ID: 7465070
    [No Abstract]   [Full Text] [Related]  

  • 3. [Oxyfedrine in coronary therapy].
    Wallner H; Sternitzke N; Schieffer H
    ZFA (Stuttgart); 1980 Mar; 56(9 Suppl):612-6. PubMed ID: 7234092
    [No Abstract]   [Full Text] [Related]  

  • 4. Oxyfedrine and cardiac inotropism in coronary artery disease.
    Krishnaswami S; Sathyamurthy I; Mao R; Padmakumar P
    Indian Heart J; 1984; 36(3):161-5. PubMed ID: 6490047
    [No Abstract]   [Full Text] [Related]  

  • 5. Oxyfedrine on left ventricular performance.
    Manchanda SC; Reddy KS; Kasturi TE
    Indian Heart J; 1980; 32(6):339-41. PubMed ID: 7228080
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comparative studies of L- as well as DL-oxyfedrine in healthy people and patients with chronic ischemic heart diseases].
    Teichmann W; Lukesch KH; Rikirsch P; Schäbitz J; Schmidt GA; Vogel HC; Sziegoleit W; Enke H
    Z Arztl Fortbild (Jena); 1976 May; 70(10):554-9. PubMed ID: 782052
    [No Abstract]   [Full Text] [Related]  

  • 7. [Glycoside and coronary therapy with Ildamen-Novodigal].
    Moosdorf S; Reincke J
    Ther Ggw; 1974 Nov; 113(11):1921-39. PubMed ID: 4462219
    [No Abstract]   [Full Text] [Related]  

  • 8. Echocardiographic evaluation of acute administration of oxyfedrine in patients with coronary artery disease.
    Maione S; Teti G; Vigorito C; Perticone F; Serino C; Giunta A; Condorelli M
    Curr Med Res Opin; 1981; 7(4):241-6. PubMed ID: 7226873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical evaluation of Ildamen].
    Krzemińska-Pakuła M; Musiał WJ
    Pol Tyg Lek; 1979 Dec; 34(52):2053-5. PubMed ID: 396524
    [No Abstract]   [Full Text] [Related]  

  • 10. [Suppression of myocardial lipid peroxidation during preventive treatment of transitory coronary insufficiency with myophedrine].
    Litvitskiĭ PF; Kogan AKh; Kudrin AN; Luk'ianova LO; Ol'binskaia LI
    Farmakol Toksikol; 1981; 44(3):303-7. PubMed ID: 7286187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immediate action of oxyphedrin as evaluated using the exertion test in coronary patients].
    Velasco Rami JA; Tormo Alfonso V; Roda Nicolas J; Serra Sister E
    Rev Esp Cardiol; 1977; 30(1):17-21. PubMed ID: 854620
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of beta-blocking agents and beta stimulators on the intracardiac hemodynamics and myocardial contraction in ischemic heart disease].
    At'kov OIu; Krol VA; Chumburidze VB
    Ter Arkh; 1977; 49(10):57-60. PubMed ID: 22937
    [No Abstract]   [Full Text] [Related]  

  • 13. [Long-term therapy of angina pectoris. Evaluation of the effectiveness and tolerance of oxyfedrine in ambulatory patients].
    Schieffer H; Sternitzke N
    Fortschr Med; 1984 May; 102(19):551-6. PubMed ID: 6429021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of nonachlazine and oxyphedrin on a focus of myocardial ischemia].
    Chichkanov GG; Bogolepov AK
    Biull Eksp Biol Med; 1978 Dec; 86(12):691-4. PubMed ID: 728611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Reperfusion damages to the heart in acute transitory coronary failure and their prevention with myophedrin].
    Vasilevskaia TA; Litvitskiĭ PF
    Biull Eksp Biol Med; 1985 Jul; 100(7):97-100. PubMed ID: 4016248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The effect of oxyfedrine on cardiac performance in coronary patients. Tests using electrocardiographic and metabolic parameters in atrial stimulation].
    Kugler VG; Priester G; Westermann KW
    Arzneimittelforschung; 1975 May; 25(5):836-7. PubMed ID: 1101898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of drugs on myocardial perfusion scanning and wall motion in patients with coronary insufficiency.
    Simon H; Felix R; Hedde J
    Acta Med Scand Suppl; 1978; 615():85-91. PubMed ID: 358767
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effects of oxyfedrine on myocardial infarct size following coronary artery occlusion in rats (author's transl)].
    Chiariello M; Brevetti G; Petillo F; Ferro G; Giasi M; Condorelli M
    G Ital Cardiol; 1981; 11(3):373-9. PubMed ID: 6116640
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of antianginal agents with a beta-adrenostimulating component of their action on the ischemic myocardium].
    Kaverina NV; Chichkanov GG; Bogolepov AK; Azvolinskaia TN; Matsievskiĭ DD
    Farmakol Toksikol; 1982; 45(4):37-41. PubMed ID: 6127232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of the partial beta-adrenergic receptor agonist, oxyfedrine, on regional myocardial blood flow and left ventricular function in patients with coronary artery disease].
    Dirschinger J; Fleck E; Rudolph W
    Herz; 1982 Dec; 7(6):351-7. PubMed ID: 7160821
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.